Trans Genic Inc. (2342.T)

JPY 159.0

(17.78%)

Annual Income Statements

(In JPY)
Breakdown 2024 2023 2022 2021 2020
Revenue 13.08 Billion 11.42 Billion 12.57 Billion 11.04 Billion 11.04 Billion
Cost of Revenue 10.83 Billion 9.43 Billion 8.74 Billion 8.26 Billion 9.26 Billion
Gross Profit 2.24 Billion 1.99 Billion 3.83 Billion 2.77 Billion 1.77 Billion
Operating Expenses 2.15 Billion 2.01 Billion 1.99 Billion 1.88 Billion 2 Billion
Selling, General and Administrative Expenses 2.14 Billion 2.01 Billion 1.99 Billion 1.88 Billion 1.6 Billion
Research and Development Expenses - 37 Million 40 Million 26 Million 38 Million
Other Expenses 2.15 Billion -15.58 Million -18.5 Million 21.57 Million -
Cost and Expenses 12.99 Billion 11.45 Billion 10.73 Billion 10.15 Billion 11.26 Billion
Operating Income 89.43 Million -25.15 Million 1.83 Billion 893.19 Million 174 Million
Interest Expense 47.47 Million 28.46 Million 22.63 Million 27.27 Million 32.21 Million
Income Tax Expense 39.09 Million 108.09 Million 907.68 Million 152.76 Million 191 Million
Earnings before Tax 43.08 Million -331.8 Million 2.76 Billion 695.2 Million -249 Million
Net Income 4.08 Million -409.66 Million 1.87 Billion 546.28 Million -440 Million
Earnings Per Share Basic 0.24 -24.32 109.52 31.45 -25.33
Earnings Per Share Diluted 0.24 -24.32 109.31 31.45 -25.33
Weighted Average Shares Outstanding 16.8 Million 16.84 Million 17.13 Million 17.36 Million 17.36 Million
Weighted Average Shares Outstanding (Diluted) 16.8 Million 16.84 Million 17.16 Million 17.36 Million 17.36 Million
Gross Margin 0.17 0.17 0.31 0.25 0.16
EBIT Margin 0.02 0.01 0.16 0.11 0.04
Profit Margin 0.00 -0.04 0.15 0.05 -0.04
EBITDA 240.95 Million -119.83 Million 3.01 Billion 975.05 Million 2.41 Million
Earnings Before Tax Margin 0.01 -0.00 0.15 0.08 0.02

Income Statement Charts